Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03608046
Title Avelumab Combined With Cetuximab and Irinotecan for Treatment Refractory Metastatic Colorectal Microsatellite Stable Cancer (AVETUXIRI)
Acronym AVETUXIRI
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Cliniques universitaires Saint-Luc- Universite Catholique de Louvain
Indications
Therapies
Age Groups: adult | senior
Covered Countries BEL

Additional content available in CKB BOOST